Back
ResMed Inc. (RMD)
Health CareRMD · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$203.85
−2.20%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$9.51
ROE
25.2%
Gross margin
62.2%
Debt/Equity
0.13x
Revenue growth
10.8%
ResMed Inc. — company intelligence
Earnings surprises
Q3 2026$2.86 vs $2.82 est+1.3%
Q2 2026$2.81 vs $2.75 est+2.1%
Q1 2026$2.55 vs $2.58 est-1.2%
Q1 2001$0.05 vs $0.04 est+16.6%
Insider activity · 90 days
0 buys1 sellnet -269 shares
Farrell Michael J.other 4,991 · Jun 8, 2026
Rider Michael JSell 269 · Jun 1, 2026
Farrell Michael J.other 4,991 · May 7, 2026
Recent SEC filings
4 — Insider transaction reportJul 9, 2026
8-K — Material event reportJul 7, 2026
4 — Insider transaction reportJun 9, 2026
Latest news
Why ResMed (RMD) Stock Is Trading Up Today — Yahoo · 1w ago
ResMed (RMD) Upgraded to Buy: Here's Why — Yahoo · 1w ago
Wall Street Analysts Think ResMed (RMD) Could Surge 28.21%: Read This Before Placing a Bet — Yahoo · 1w ago
ResMed (RMD) Stock Looks Cheap Even As The Market Stays Cautious — Yahoo · 1w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About ResMed Inc.
Weekly undervalued picks (like RMD)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.